Exascale Labs Holdings Inc. (XLAB)

NASDAQ: XLAB · Real-Time Price · USD

4.485

+0.095 (2.16%)

At close: Sep 8, 2026, 4:00 PM EDT

4.400

+0.010 (0.23%)

Pre-market: Sep 9, 2026, 6:33 AM EDT

Exascale Labs Holdings Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024
Revenue	13.1	7.02	1.32
Revenue Growth	-	431.83%	-
Cost of Revenue	10.99	5.91	1.26
Gross Profit	2.12	1.11	0.06
Selling, General & Admin	1.6	1.35	0.54
Research & Development	3.92	2.8	1.37
Operating Expenses	5.52	4.15	1.9
Operating Income	-3.4	-3.04	-1.85
Other Non Operating Income (Expenses)	-6	-4.61	-3.11
Pretax Income	-9.4	-7.66	-4.96
Net Income	-9.4	-7.66	-4.96
Net Income to Common	-9.4	-7.66	-4.96
Net Income Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024
Free Cash Flow	-4.01	-1.01	-0.59
Gross Margin	16.14%	15.75%	4.21%
Operating Margin	-25.96%	-43.40%	-139.93%
Profit Margin	-71.74%	-109.18%	-375.73%
Free Cash Flow Margin	-30.62%	-14.44%	-44.63%
EBITDA	-3.39	-3.04	-1.84
EBITDA Margin	-25.91%	-43.31%	-139.62%
D&A For EBITDA	0.01	0.01	0
EBIT	-3.4	-3.04	-1.85
EBIT Margin	-25.96%	-43.40%	-139.93%
Advertising Expenses	-	0.16	0.03

SEC Filings: 10-K · 10-Q